Your browser doesn't support javascript.
loading
Case report: Triple whammy: Synchronous radiotherapy induced glioblastoma multiforme and papillary thyroid cancer following nasopharyngeal carcinoma.
Palaniandy, Kamalanathan; Kamarudin, Zalikha; Wong, Yin Ping; Mohamed Mukari, Shahizon Azura; Jiau, Winnie Xiao Hui; Bakar, Azizi Abu.
Afiliação
  • Palaniandy K; Division of Neurosurgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia.
  • Kamarudin Z; Division of Neurosurgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia.
  • Wong YP; Department of Pathology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Mohamed Mukari SA; Department of Radiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Jiau WXH; Department of Rehabilitation Medicine, Hospital Rehabilitasi Cheras, Kuala Lumpur, Malaysia.
  • Bakar AA; Division of Neurosurgery, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Malaysia.
Front Oncol ; 12: 1012395, 2022.
Article em En | MEDLINE | ID: mdl-36452494
Secondary malignancies following radiotherapy are well documented, with an estimated incidence of 5%. These may manifest as carcinomas, gliomas, or sarcomas within the previous radiation field. Glioblastoma multiforme following radiotherapy for nasopharyngeal carcinoma is an uncommon occurrence and carries a poor prognosis, whereas papillary thyroid carcinoma following radiotherapy is well documented, though the exact incidence is not well documented. The occurrence of synchronous radiotherapy-induced malignancy over both sites has not been described in the literature before. We describe a middle-aged gentleman diagnosed with glioblastoma multiforme and papillary thyroid carcinoma 6 years after radiotherapy for nasopharyngeal carcinoma. Though our case is the first reported case of a synchronous tumour of its nature, it is likely that such cases are under-reported. Long-term vigilance for loco-regional radiotherapy-induced secondary malignancies is a must, and the presence of a second distinct secondary malignancy must be entertained.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malásia

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malásia